HU9700060D0 - New compound, it's production and it's use as active component of a medicine - Google Patents

New compound, it's production and it's use as active component of a medicine

Info

Publication number
HU9700060D0
HU9700060D0 HU9700060A HU9700060A HU9700060D0 HU 9700060 D0 HU9700060 D0 HU 9700060D0 HU 9700060 A HU9700060 A HU 9700060A HU 9700060 A HU9700060 A HU 9700060A HU 9700060 D0 HU9700060 D0 HU 9700060D0
Authority
HU
Hungary
Prior art keywords
medicine
production
active component
new compound
compound
Prior art date
Application number
HU9700060A
Other languages
English (en)
Other versions
HUT76827A (en
Inventor
Ralf Anderskewitz
Franz Birke
Armin Fuegner
Hubert Heuer
Christopher Meade
Ernst-Otto Renth
Kurt Schromm
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of HU9700060D0 publication Critical patent/HU9700060D0/hu
Publication of HUT76827A publication Critical patent/HUT76827A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU9700060A 1994-07-13 1995-06-03 Benzamidin derivative with ltb4-receptor antagonist activity, its preparation and use as a drug HUT76827A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4424714A DE4424714A1 (de) 1994-07-13 1994-07-13 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff

Publications (2)

Publication Number Publication Date
HU9700060D0 true HU9700060D0 (en) 1997-02-28
HUT76827A HUT76827A (en) 1997-11-28

Family

ID=6523048

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700060A HUT76827A (en) 1994-07-13 1995-06-03 Benzamidin derivative with ltb4-receptor antagonist activity, its preparation and use as a drug

Country Status (25)

Country Link
US (1) US5686496A (hu)
EP (1) EP0770058A1 (hu)
JP (1) JPH10502646A (hu)
KR (1) KR970704674A (hu)
CN (1) CN1152303A (hu)
AU (1) AU2736895A (hu)
BG (1) BG101104A (hu)
BR (1) BR9508395A (hu)
CA (1) CA2194886A1 (hu)
CO (1) CO4410185A1 (hu)
CZ (1) CZ8297A3 (hu)
DE (1) DE4424714A1 (hu)
EE (1) EE9700065A (hu)
FI (1) FI970095A0 (hu)
HR (1) HRP950363A2 (hu)
HU (1) HUT76827A (hu)
IL (1) IL114572A0 (hu)
MX (1) MX9700245A (hu)
NO (1) NO970123D0 (hu)
PE (1) PE35196A1 (hu)
PL (1) PL318114A1 (hu)
SK (1) SK1897A3 (hu)
WO (1) WO1996002496A1 (hu)
YU (1) YU45395A (hu)
ZA (1) ZA955781B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191169B1 (en) 1992-08-28 2001-02-20 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
US6486181B1 (en) 1992-08-28 2002-11-26 City Of Hope Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
EP0743064A1 (en) * 1995-05-17 1996-11-20 Eli Lilly And Company Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19718334A1 (de) 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ID24720A (id) 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6528491B2 (en) * 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
CA2433451A1 (en) * 2001-01-16 2002-07-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
IL160208A0 (en) * 2001-08-31 2004-07-25 Neurochem Int Ltd Amidine derivatives for treating amyloidosis
EP1623231A2 (en) * 2003-05-06 2006-02-08 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
KR100682199B1 (ko) * 2004-07-05 2007-02-12 동화약품공업주식회사 알러지성 염증 질환의 예방 및 치료용 조성물
EP1765333A4 (en) * 2004-07-14 2008-06-18 Inflammation Res Ct Company Lt PROCESS FOR INHIBITING TUMOR METASTASES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
DK0902013T3 (da) * 1992-02-05 2002-03-25 Boehringer Ingelheim Pharma Hidtil ukendte amidinderivater, deres fremstilling og anvendelse som lægemidler med LTB4-antagonistisk virkning

Also Published As

Publication number Publication date
PE35196A1 (es) 1996-09-05
HUT76827A (en) 1997-11-28
DE4424714A1 (de) 1996-01-18
SK1897A3 (en) 1997-08-06
YU45395A (sh) 1997-12-05
WO1996002496A1 (de) 1996-02-01
CZ8297A3 (en) 1997-09-17
PL318114A1 (en) 1997-05-12
CA2194886A1 (en) 1996-02-01
EE9700065A (et) 1997-08-15
EP0770058A1 (de) 1997-05-02
BG101104A (en) 1998-04-30
IL114572A0 (en) 1995-11-27
BR9508395A (pt) 1997-12-23
CN1152303A (zh) 1997-06-18
FI970095A (fi) 1997-01-10
ZA955781B (en) 1996-02-22
US5686496A (en) 1997-11-11
CO4410185A1 (es) 1997-01-09
NO970123L (no) 1997-01-10
HRP950363A2 (en) 1997-08-31
AU2736895A (en) 1996-02-16
FI970095A0 (fi) 1997-01-10
MX9700245A (es) 1997-05-31
NO970123D0 (no) 1997-01-10
JPH10502646A (ja) 1998-03-10
KR970704674A (ko) 1997-09-06

Similar Documents

Publication Publication Date Title
HUP9900028A3 (en) Pharmaceutically active quinazoline compounds, their production, use thereof and medicament containing them
HRP960365B1 (en) New medicaments and the use thereof
AU6691194A (en) N'-heterocyclyl-n-benzofuranyl urea derivatives and their analogs as acat inhibitors
HU9700060D0 (en) New compound, it's production and it's use as active component of a medicine
HUP9802807A3 (en) 1,3,8-triazo-spiro[4,5]decan-4-on derivatives, their use, production thereof and medicaments containing the same
HUP9603302A3 (en) Biaromatic compounds bearing a 4-adamantyl-phenyl group, pharmaceutical and cosmetic compositions containing them and use of the cosmetic compositions
IL125775A0 (en) Use of a zwitterion composition and a pharmaceutical composition containing the same
IL107222A (en) Preparation of L-5-(2-acetoxy-propionylamino)-2,4,6-triiodo-isophthalic acid dichloride
ZA941199B (en) Physiologically active compound HS-1 and process for the preparation of the same
AU3011095A (en) 2,3-bridged 1,4-dihydropyridines, processes for their preparation and their use as medicaments
ZA902566B (en) 2-substituted n,n'-ditrimethoxybenzoyl piperazines,a preparation process of the samde and therapeutic compositions containing them
EP0692476A3 (de) Verbessertes Verfahren zur Herstellung von N,N'-Carbonyldiazolen, insbesondere N,N'-Carbonyldiimidazol
ZA916638B (en) Phosphonopyrrolidine-and piperidine-containing pseudopeptides of the statin type,a process for their preparation and their use as medicaments against retroviruses
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
HK1016166A1 (en) 5-naphthalen-1-yl-1, 3-dioxane derivatives, preparation and therapeutical use thereof
EP0694604A3 (fr) Utilisation du 1,3-uncadécadién-5-yne à titre d'ingrédient parfumant
AU7057691A (en) Piperazine compound, production thereof, and medicinal use thereof
AU2886595A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing the latter, as well as process for the production of the complexes and agents
HUP9600268A1 (en) Herbicidal [1,2,4] thiadiazoles, composition, producing and using them
DE69011356T2 (de) 6'Deoxy-6'-halogenoneplanosin A und dessen Herstellung.
GB2280438B (en) Carboxymethylidenecycloheptimidazole derivatives,method of manufacturing the same and therapeutic agents containing these compounds
PL313116A1 (en) Application of n-alkalated 1,4-dihydropridinocarboxylic esters as drugs
AU7358896A (en) 1-{4-(4'-sulfanilyl)phenyl}urea and derivatives for the treatment of leishmaniasis
IL116596A0 (en) 8-oxo-5, 8 dihydro-6h-dibenzo (a,g)quinolizine-13-propanoic acid derivatives their preparation and their therapeutic application
ZA98119B (en) Process for the preparation of 4"-deoxyerythromycins a and b

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee